| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 2D 1H-15N HSQC | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 2 | 2D 13C CACO | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 3 | 2D 13C CBCACO | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 4 | 2D 13C CON | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 5 | 2D 1H-15N HSQC | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 6 | 3D HNCO | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |
| 7 | 3D 13C (H)CBCACON | 450 uM [U-100% 13C; U-100% 15N] NTD (44-180) of N protein from SARS-CoV-2, 0.03 % NaN3, 150 mM KCl, 95 % H2O, 5 % [U-2H] D2O | 95% H2O/5% D2O | 170 mM | 6.5 | 1 atm | 298 | Bruker AVANCE III 950 |